Skip to content

Emotional Experience and Adherence in Chess Games Against Human and Avatar-AI Opponents in Patients with Affective Disorders

Emotional Experience and Adherence in Chess Games Against Human and Avatar-AI Opponents in Patients with Affective Disorders - Caissa

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00040989
Enrollment
40
Registered
2026-07-14
Start date
2026-08-17
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F30-F39

Interventions

Group 1: Chess against an Avatar AI Participants play a game of chess against an interactive, AI-powered avatar that interacts via voice on a screen and plays on a digital chessboard. The avatar inter

Sponsors

Charité – Universitätsmedizin Berlin Klinik für Psychiatrie und Psychotherapie, Campus Benjamin Franklin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Ability to provide written informed consent and willingness to participate in the study Sufficient proficiency in German to understand instructions, complete questionnaires, and engage in interactions Basic computer literacy (mouse/keyboard operation) Diagnosis of an affective disorder as documented by the treating physician

Exclusion criteria

Exclusion criteria: Clinical condition that prevents safe participation Severe cognitive impairment (e.g., dementia, delirium) or neurological disorders that significantly impair task performance Lack of sufficient proficiency in German

Design outcomes

Primary

MeasureTime frame
Differences in adherence between the two types of opponents (human vs. avatar AI), operationalized via the voluntary use and duration of the optional game extension (in minutes)

Secondary

MeasureTime frame
1. Interaction Quality and User Experience What: Subjective satisfaction, perceived trust, interaction quality, alliance with the playing partner, and social presence When: After each chess session How: Questionnaire-based — adapted version of the Working Alliance Inventory (WAI), adapted version of the Networked Minds Measure of Social Presence, as well as additional self-developed items on game satisfaction 2. Psychometric Course What: General psychological well-being, depressive symptom severity, generalized self-efficacy, and affective reactions When: Baseline, after each playing session How: WHO-5 Well-Being Index (World Health Organization – Five Well-Being Index), PHQ-9 (Patient Health Questionnaire-9), GSE (General Self-Efficacy Scale), SAM (Self-Assessment Manikin) 3. Influence of Individual Chess Characteristics What: Association between prior chess experience, subjective playing strength, and the primary endpoint (adherence) When: Chess experience and playing strength are assessed once at baseline; the association with adherence is evaluated across sessions How: Self-report questionnaire on chess experience (baseline); adherence measure as described above 4. Influence of Demographic and Clinical Factors What: Influence of demographic variables (age, gender, level of education) and clinical factors on the perception of the opponent types and the interaction experience When: Demographics and clinical parameters are assessed at baseline; interaction experience after each session How: Demographic questionnaire, PHQ-9, combined with the interaction questionnaires (WAI, Social Presence) 5. Role of Prior Digital/AI Experience What: Association between prior experience with digital applications and AI systems and the acceptance, interaction quality, as well as perceived human-like traits of the avatar opponent When: Prior digital/AI experience is assessed at baseline; acceptance and perception after the avatar session How: Self-report quest

Countries

Germany

Contacts

Public ContactNils Opel

Charité – Universitätsmedizin Berlin Klinik für Psychiatrie und Psychotherapie, Campus Benjamin Franklin

nils.opel@charite.de+49 30 450 517-522 /50

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026